ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

EYE vs JNJ // GROSS PROFIT MARGIN

National Vision Holdings Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: EYE 3 — JNJ 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EYE VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC EYE JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 67.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 4.40% 25.50% -21.10 JNJ /roic <GO>
EV/EBITDA & P/E Valuation 12.4x 18.5x -6.10 EYE /valuation <GO>
Free Cash Flow Yield 5.58% 2.97% +2.61 EYE /fcf-yield <GO>
Operating Margin 3.00% 34.70% -31.70 JNJ /operating-margins <GO>
Net Profit Margin 1.50% 28.50% -27.00 JNJ /net-margins <GO>
Revenue Growth (YoY) 9.00% 6.00% +3.00 EYE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.59 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.6 62.1 -16.50 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 41.3x 23.0x +18.30 JNJ /forward-pe <GO>
Enterprise Scale & Market Cap $1.32B $662.49B -$661.18B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR EYE REV JNJ REV EYE GROSS % JNJ GROSS % EYE FCF JNJ FCF
FY 2025 $1.99B $94.19B — 67.9% $73.5M $19.70B
FY 2024 $1.82B $88.82B — 69.1% $38.1M $19.84B
FY 2023 $1.76B $85.16B — — $173.0M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EYE // BETA —
JNJ // BETA 1.08